These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31436286)

  • 1. Bupenorphine in Wisconsin Drivers: Concerns for Impairment?
    Edwards LD
    J Anal Toxicol; 2019 Sep; 43(8):644-650. PubMed ID: 31436286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugged Driving in Wisconsin: Oral Fluid Versus Blood.
    Edwards LD; Smith KL; Savage T
    J Anal Toxicol; 2017 Jul; 41(6):523-529. PubMed ID: 28830121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes.
    Oechsler S; Skopp G
    Forensic Sci Int; 2010 Feb; 195(1-3):73-7. PubMed ID: 20006453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
    Truver MT; Palmquist KB; Swortwood MJ
    J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS-MS analysis of buprenorphine and norbuprenorphine in whole blood from suspected drug users.
    Seldén T; Roman M; Druid H; Kronstrand R
    Forensic Sci Int; 2011 Jun; 209(1-3):113-9. PubMed ID: 21306845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS.
    Berg T; Jørgenrud B; Strand DH
    J Anal Toxicol; 2013 Apr; 37(3):159-65. PubMed ID: 23423312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological and Demographic Profiles of Phencyclidine-Impaired Driving Cases in Houston.
    Lee D; Stout P
    J Anal Toxicol; 2020 Apr; 44(5):499-503. PubMed ID: 32049354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry.
    Polettini A; Huestis MA
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):447-59. PubMed ID: 11339288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated Method for the Quantification of Buprenorphine in Postmortem Blood Using Solid-Phase Extraction and Two-Dimensional Gas Chromatography-Mass Spectrometry.
    Nahar LK; Andrews R; Paterson S
    J Anal Toxicol; 2015 Sep; 39(7):519-25. PubMed ID: 25962609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forensic Toxicology Program: alcohol and drug testing in Wisconsin drivers.
    Harding P; Liddicoat LJ
    WMJ; 2003; 102(6):79-83. PubMed ID: 14658575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine Prevalence in DUID Cases in Southwestern Virginia: Case Studies and Observations.
    Kuhlman JJ; Harris C; Wright T
    J Anal Toxicol; 2022 Feb; 46(1):89-98. PubMed ID: 33186447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan in Wisconsin drivers.
    Cochems A; Harding P; Liddicoat L
    J Anal Toxicol; 2007 May; 31(4):227-32. PubMed ID: 17555648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of safety margins for whole blood concentrations of alcohol and nineteen drugs in driving under the influence cases.
    Kristoffersen L; Strand DH; Liane VH; Vindenes V; Tvete IF; Aldrin M
    Forensic Sci Int; 2016 Feb; 259():119-26. PubMed ID: 26773222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatonephritis and massive ingestion of buprenorphine].
    Houdret N; Asnar V; Szostak-Talbodec N; Leteurtre E; Humbert L; Lecomte-Houcke M; Lhermitte M; Paris JC
    Acta Clin Belg; 1999; 53 Suppl 1():29-31. PubMed ID: 10216978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting categories of drugs used by suspected drug-impaired drivers using the Drug Evaluation and Classification Program tests.
    Porath AJ; Beirness DJ
    Traffic Inj Prev; 2019; 20(3):255-263. PubMed ID: 30946603
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study.
    Pirnay S; Bouchonnet S; Hervé F; Libong D; Milan N; D'Athis P; Baud F; Ricordel I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):335-42. PubMed ID: 15203048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carfentanil in Impaired Driving Cases and the Importance of Drug Seizure Data.
    Tiscione NB; Alford I
    J Anal Toxicol; 2018 Sep; 42(7):476-484. PubMed ID: 29659874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug recognition expert evaluations made using limited data.
    Smith JA; Hayes CE; Yolton RL; Rutledge DA; Citek K
    Forensic Sci Int; 2002 Dec; 130(2-3):167-73. PubMed ID: 12477639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-Year Study of Δ 9-tetrahydrocannabinol Concentrations in Drivers: Examining Driving and Field Sobriety Test Performance,
    Declues K; Perez S; Figueroa A
    J Forensic Sci; 2016 Nov; 61(6):1664-1670. PubMed ID: 27479468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid quantification of buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine by LC-MS-MS.
    Hegstad S; Khiabani HZ; Øiestad EL; Berg T; Christophersen AS
    J Anal Toxicol; 2007 May; 31(4):214-9. PubMed ID: 17555645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.